A5006367171- Amyloidosis: Diagnosis, Treatment, Outcomes
- Parathyroid Disorders and Treatments
- Cardiomyopathy and Myosin Studies
- Cardiac Arrhythmias and Treatments
- Peptidase Inhibition and Analysis
- Sarcoidosis and Beryllium Toxicity Research
- Cardiac pacing and defibrillation studies
- Cardiac electrophysiology and arrhythmias
- Cardiovascular Function and Risk Factors
- Cardiovascular Effects of Exercise
- Vasculitis and related conditions
- Atrial Fibrillation Management and Outcomes
- Cardiac tumors and thrombi
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Health Systems, Economic Evaluations, Quality of Life
- Cerebrovascular and Carotid Artery Diseases
- Clinical practice guidelines implementation
- Cardiac Valve Diseases and Treatments
- Renal Diseases and Glomerulopathies
- Dermatological and Skeletal Disorders
- Eosinophilic Disorders and Syndromes
- Pancreatitis Pathology and Treatment
- Hormonal Regulation and Hypertension
- Cardiac Structural Anomalies and Repair
Centro de Investigación en Red en Enfermedades Cardiovasculares
2022-2024
Hospital Universitario Puerta de Hierro Majadahonda
2022-2024
Spanish National Centre for Cardiovascular Research
2023-2024
Instituto de Salud Carlos III
2024
ERN GUARD-Heart
2024
Universidad de Navarra
2022-2023
Complejo Hospitalario de Navarra
2022
Although transthyretin cardiac amyloidosis (ATTR-CA) is often underdiagnosed, clinical suspicion essential for early diagnosis.
Abstract Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM) is increasingly recognized as a cause of heart failure in the elderly. Although wild‐type transthyretin amyloidosis most frequent form ATTR‐CM found elderly, hereditary (ATTRv) can also occur. We sought to determine prevalence ATTRv among elderly patients, identify predictors and evaluate clinical consequences positive genetic testing this population. Methods results Prevalence patients (≥70 years) was assessed cohort 300...
Wild-type transthyretin amyloidosis (ATTRwt amyloidosis) is primarily diagnosed in elderly men but diagnoses younger patients and women have recently increased.
Although sudden death (SD) is a recognized complication of cardiac amyloidosis, there scarce data about its incidence, mechanisms, and predictors. The aim this study was to describe incidence SD analyze possible risk factors.
BACKGROUND: Among inherited cardiomyopathies involving the left ventricle, whether dilated or not, certain genotypes carry a well-established arrhythmic risk, notably manifested as sustained monomorphic ventricular tachycardia (SMVT). Nonetheless, precise localization and electrophysiological profile of this substrate remain undisclosed across different genotypes. METHODS: Patients diagnosed with cardiomyopathy ventricle involvement due to high-risk genetic variants SMVT treated by study...